1. Home
  2. CUTR vs NXL Comparison

CUTR vs NXL Comparison

Compare CUTR & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUTR
  • NXL
  • Stock Information
  • Founded
  • CUTR 1988
  • NXL 2010
  • Country
  • CUTR United States
  • NXL United States
  • Employees
  • CUTR N/A
  • NXL N/A
  • Industry
  • CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NXL Medical Specialities
  • Sector
  • CUTR Health Care
  • NXL Health Care
  • Exchange
  • CUTR Nasdaq
  • NXL Nasdaq
  • Market Cap
  • CUTR 9.2M
  • NXL 10.0M
  • IPO Year
  • CUTR 2004
  • NXL 2022
  • Fundamental
  • Price
  • CUTR $0.33
  • NXL $2.62
  • Analyst Decision
  • CUTR Hold
  • NXL Hold
  • Analyst Count
  • CUTR 3
  • NXL 1
  • Target Price
  • CUTR $3.00
  • NXL N/A
  • AVG Volume (30 Days)
  • CUTR 305.0K
  • NXL 513.2K
  • Earning Date
  • CUTR 11-07-2024
  • NXL 11-08-2024
  • Dividend Yield
  • CUTR N/A
  • NXL N/A
  • EPS Growth
  • CUTR N/A
  • NXL N/A
  • EPS
  • CUTR N/A
  • NXL N/A
  • Revenue
  • CUTR $155,210,000.00
  • NXL $162,078.00
  • Revenue This Year
  • CUTR N/A
  • NXL $56.86
  • Revenue Next Year
  • CUTR $4.61
  • NXL $167.44
  • P/E Ratio
  • CUTR N/A
  • NXL N/A
  • Revenue Growth
  • CUTR N/A
  • NXL 26.00
  • 52 Week Low
  • CUTR $0.28
  • NXL $0.25
  • 52 Week High
  • CUTR $4.97
  • NXL $4.49
  • Technical
  • Relative Strength Index (RSI)
  • CUTR 37.33
  • NXL 33.64
  • Support Level
  • CUTR $0.33
  • NXL $2.92
  • Resistance Level
  • CUTR $0.39
  • NXL $4.49
  • Average True Range (ATR)
  • CUTR 0.04
  • NXL 0.40
  • MACD
  • CUTR 0.00
  • NXL -0.24
  • Stochastic Oscillator
  • CUTR 3.68
  • NXL 12.62

About CUTR Cutera Inc.

Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: